Main navigation contact us Breadcrumb Home Investors Investor information Analysts coverage and consensus Analysts coverage and consensus Related navigation Disclaimer Have a question? FAQ Contact us Services Print this page RSS Analyst coverage Below are listed the sell-side analysts that cover Givaudan on a regular basis. Institution Name Recommendation Baader Helvea Andreas Von Arx add Bank of America Matthew Yates buy Barclays Sebastian Satz underweight Berenberg Bank James Targett buy Bernstein Gunther Zechmann underweight Bryan Garnier Loic Morvan buy Crédit Industriel et Commercial Virginie Royere Roumage neutral Citi Investment Research Mubasher Chaudhry neutral Credit Suisse Samuel Perry underperform Davy Research Cathal Kenny outperform Deutsche Bank Virginie Boucher-Ferté hold EXANE BNP Paribas Heidi Vesterinen neutral Goldman Sachs International Georgina Iwamoto neutral Jefferies Charles Bentley underperform JP Morgan Celine Pannuti neutral Kepler Cheuvreux Patrick Roquas hold Liberum Adam Collins hold Mirabaud Daniel Jelovcan hold Morgan Stanley Lisa De Neve equal weight Morningstar Rob Hales sell Redburn Tony Jones buy Société Générale Thomas Swoboda sell Stifel Europe Bank AG Isha Sharma hold UBS Charles Eden buy Vontobel Jean-Philippe Bertschy buy Zürcher Kantonalbank Daniel Buerki outperform Recommendation Buy 7 Hold 9 Sell 5 Latest update 29 October Consensus forecasts The consensus forecasts, compiled by Givaudan, are based on emails and reports received between 18 and 29 October 2021. Disclaimer: The consensus forecast set out below results from regular research reports made by analysts currently covering Givaudan, as detailed in the list below. This list has been drawn up to the best of Givaudan’s knowledge but does not purport to be comprehensive of all institutions publishing financial research on Givaudan. Any opinions, forecasts, estimates, projections or predictions regarding Givaudan’s performance made by the analysts are exclusively theirs and do not represent the opinions, forecasts, estimates, projections or predictions of Givaudan or its management. The publication of this information on this website does not imply that Givaudan endorses, or concurs with, the reports, conclusions or recommendations of the cited analysts. Givaudan disclaims any liability for the accuracy or completeness of such information and does not assume any obligation to update it even if it becomes aware of any changes. This information is provided for ease of reference only and does not constitute an offer or solicitation to buy, hold or sell Givaudan securities. in millions of Swiss francs FY 2020 A FY 2021 E FY 2022 E discrete Q4 2021 Group sales 6,322 High 6,727 7,224 1,694 Average 6,682 7,082 1,626 Low 6,580 6,944 1,513 LFL Group sales growth (%) 4.0% High 7.7 6.4 7.4 Average 7.1 4.8 5.4 Low 6.2 3.0 3.4 Fragrance & Beauty ( F&B) sales 2,924 High 3,126 3,387 775 Average 3,099 3,259 746 Low 2,990 3,170 639 LFL F&B sales growth (%) 5.4% High 8.1 6.0 7.2 Average 7.1 5.0 3.1 Low 5.9 4.0 -1.5 Taste & Wellbeing (T&W) sales 3,398 High 3,606 3,947 889 Average 3,584 3,820 875 Low 3,534 3,693 852 LFL T&W sales growth (%) 2.8% High 7.8 7.6 9.7 Average 7.1 4.8 7.4 Low 5.5 3.0 4.6 EBITDA reported 1,397 High 1,603 1,708 Average 1,528 1,599 Low 1,456 1,446 Net Income reported 743 High 967 1,064 Average 874 960 Low 769 855 Free Cash Flow reported 811 High 1,048 1,106 Average 890 920 Low 653 765 Free Cash Flow as a % of sales 12.8% High 15.6 15.6 Average 13.2 12.9 Low 9.7 10.7 Price Target High 5,000 Average 4,164 Low 2,700 Recommendation Buy 7 Hold 9 Sell 5 Number of estimates 21 Latest update 29-10-21 Footer sub menu Contact Legal Privacy notice Locations Sitemap LinkedIn Twitter Facebook Instagram Youtube © Givaudan 2021 SUSTAINABILITY Latest stories Australia Slavery Act CA Supply Chains Act UK Slavery Act STAY INFORMED Company news Publications Subscribe to news Glossary SERVICES Print this page RSS STOCK PRICE GIVN: 4,490.00 (-5.00) -0.11% Updated 2021-11-26 10:45:03 CET